A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 versus treatment of physician's choice (TPC) in patients with metastatic breast cancer who have stable brain metastases and have been previously treated with an Anthracycline, a Taxane, and Capecitabine

UCI-16-74
NCT02915744
Cancer - Brain and Nervous System
Jose Carrillo
Open
Treatment
III
Adult
Local

For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.